跳至主要内容
临床试验/NCT05439239
NCT05439239Unknown不适用

Effects of Hypoxic Repeated Sprint Training on Performance in Normoxia in Male and Female Athletes Participating in Team/Racket Sports

Université Catholique de Louvain1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2022年4月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
48
试验地点
1
主要终点
Repeated sprint cycling performance in normoxia in males and females who participate in team or racket sports.

研究概览

简要总结

With the increased participation of women in sports, it is essential to develop gender-tailored training strategies for improving exercise performance. Males and females exhibit gender-specific characteristics and they therefore respond differently to physical exercise. Improving repeated sprint ability (RSA, i.e., ability to perform repeated short duration sprints separated by brief recovery intervals) in women is important for sports performance, as it is a key factor in most team and racket sports. Repeated sprint training in hypoxia is increasingly popular in this field, as it has demonstrated further improvements in sea-level repeated sprint performance than similar training in normoxia. However, these observations are based mainly on male athletes. Whether the effects of hypoxic repeated sprint training on repeated sprint performance in normoxia differ between genders is not yet known, therefore the investigators propose to examine those possible differences in this study.

The aim of this study is to investigate whether the effects of hypoxic repeated sprint training on repeated sprint performance in normoxia differ between males and females who participate in team/racket sports.

Considering the sex-specific characteristics that males and females exhibit, the investigators hypothesize that after 7 weeks of hypoxic repeated sprint training the improvements in repeated sprint ability at sea level will be greater in males than in females.

To answer this question, the investigators will measure the following: body composition (lean body mass); body weight and height; VO2max; blood (estrogen, lactate, hemoglobin, hematocrit); repeated sprint ability (RSA) test; muscle oxygenation (concentrations for oxyhemoglobin, deoxyhemoglobin, and total hemoglobin/myoglobin); 30-s Wingate test; heart rate (HR); power output; rate of perceived exertion (RPE); visual analogue scale (VAS; pain level in legs).

The investigators will recruit 48 volunteers and they will randomly assign them into the normoxic or hypoxic training group, without giving any information about their group. The volunteers should meet the following inclusion criteria: females (on monophasic oral contraceptive pill) and males, age between 18-40 years, recreationally participating in team/racket sports min 3h/week with at least 2 years of experience prior to the study. Exclusion criteria will be: smoking, exposure to altitude >1500 m one month before the study, any health conditions or injuries that could compromise the participant's safety during training/testing, prescribed medication, performing repeated sprint training more than once per week.

Males and females, matched for VO2max and sprint performance, will perform repeated sprint training (3 sets during week 1-6, 2 sets during week 7 with 5min active recovery in between, 5 x 10s maximal sprints with 20s active recovery in between) in hypoxia or normoxia 2x/week for 7 weeks. Before and after the training period, the following tests and measurements will be performed: body composition analysis, VO2max test, blood sampling for measuring hemoglobin and estrogen concentrations and hematocrit, determination of hemoglobin mass, RSA test, muscle oxygenation assessment during RSA test, 30-s Wingate test and blood lactate measurements.

详细描述

A single blind, parallel, gender comparative, randomized controlled trial design will be used and the methodology of this study will be based on a previously applied successful protocol on males. Participants (males and females) will be randomly assigned to either the control group (repeated sprint training in normoxia; RSN) or the intervention group (repeated sprint training group in hypoxia; RSH), resulting in four groups in total (females RSN and RSH; males RSN and RSH). Due to the big number of participants required, the experiment will be split into two studies: RSN will be performed in study 1 and RSH in study 2. The experiment involves 7 weeks (week 1-7) of cycling repeated sprint training in normoxia or hypoxia, 2x/week, and two testing sessions before (week -2/-1, Pre-testing) and after (week 8/9, Post-testing) the training period. During the testing sessions, participants will complete the following exercise performance tests and measurements in normoxia: body composition assessment through DEXA (dual energy x-ray absorptiometry) and skinfold measurements, VO2max test, blood sampling at rest to measure hemoglobin and estrogen concentrations and hematocrit, determination of hemoglobin mass, repeated sprint ability (RSA) test and near-infrared spectroscopy (NIRS) measurement for muscle oxygenation, and 30-s Wingate test. Blood lactate will be measured at rest before and immediately after the following exercise performance tests: RSA and Wingate.

Preliminary visit:

During the week before Pre-testing, participants will be assessed for eligibility through a medical screening and completion of questionnaires (medical screening and physical activity/lifestyle questionnaires), after signing the informed consent related to the Pre-screening. If they are eligible and still wish to take part to the study, participants will sign the informed consent related to the study and they will get familiarized with all the experimental procedures.

Supervised training:

Participants will perform 7 weeks of cycling repeated sprint training (2x/week), starting the week after the Pre- testing and finishing the week before the Post-testing. The training sessions will take place in a hypoxic chamber consisting of a compressor, built in the laboratory. Inspired oxygen fraction (FiO2) will be set to 14.6% and 20.9% for RSH and RSN to simulate an altitude of 3000 m and 300 m, respectively. In order to blind subjects to altitude, the compressor system will also be running for RSN but with a normoxic airflow into the chamber. Temperature in the chamber will be maintained constant throughout the training program.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Females (on monophasic oral contraceptive pill)
  • •Must recreationally participating in team/racket sports min 3h/week with at least 2 years of experience prior to the study

排除标准

  • •Exposure to altitude >1500 m one month before the study
  • •Any health conditions or injuries that could compromise the participant's safety during training/testing
  • •Prescribed medication
  • •Performing repeated sprint training more than once per week.

研究组 & 干预措施

Normoxic group females

Placebo Comparator

The participants in this group (12 females) will perform a repeated sprint training in normoxia.

干预措施: Repeated sprint training (Other)

Hypoxic group females

Experimental

The participants in this group (12 females) will perform a repeated sprint training in hypoxia.

干预措施: Repeated sprint training (Other)

Normoxic group males

Placebo Comparator

The participants in this group (12 males) will perform a repeated sprint training in normoxia.

干预措施: Repeated sprint training (Other)

Hypoxic group males

Placebo Comparator

The participants in this group (12 males) will perform a repeated sprint training in hypoxia.

干预措施: Repeated sprint training (Other)

结局指标

主要结局

Repeated sprint cycling performance in normoxia in males and females who participate in team or racket sports.

时间窗: The primary outcome will be assessed twice for each participant: one time before the training program and one time after the training program. Testing will last no more than one hour.

Performance will be determined through a repeated sprint ability test on the cycle ergometer, by the number of sprints and the power output during the sprints. The repeated sprint cycling performance will be assessed before and after a 7-week training program of repeated sprints in normoxia or hypoxia.

次要结局

  • Endurance capacity assessed using a maximal effort test on the cycle ergometer, namely VO2max test.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program.)
  • Hematocrit measured using the HORIBA hematology analyzer.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)
  • Hemoglobin mass measured using the CO rebreathing method.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)
  • Lean body mass assessed by the DEXA scan.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)
  • Fat percentage measured using the skinfolds method and the DEXA scan.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)
  • Anaerobic capacity measured by the 30 s Wingate test on the cycle ergometer.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)
  • Hemoglobin concentration measured using the HORIBA hematology analyzer.(The secondary outcomes will be assessed twice for each participant: one time before the training program and one time after the training program)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验